Dimensional Fund Advisors
VNDA icon

Dimensional Fund Advisors’s Vanda Pharmaceuticals VNDA Stock Holding History

Dimensional Fund Advisors’s Portfolio VNDA Stock Details VNDA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$12.2M Sell
1,771,593
-346,835
-16% -$2.67M ﹤0.01% 2180
2025
Q4 		$18.7M Sell
2,118,428
-445,541
-17% -$2.45M ﹤0.01% 1999
2025
Q3 		$12.8M Sell
2,563,969
-21,788
-0.8% -$101K ﹤0.01% 2206
2025
Q2 		$12.2M Buy
2,585,757
+46,082
+2% +$202K ﹤0.01% 2203
2025
Q1 		$11.7M Buy
2,539,675
+51,156
+2% +$238K ﹤0.01% 2184
2024
Q4 		$11.9M Buy
2,488,519
+227,428
+10% +$1.09M ﹤0.01% 2236
2024
Q3 		$10.6M Buy
2,261,091
+247,284
+12% +$1.33M ﹤0.01% 2282
2024
Q2 		$11.4M Buy
2,013,807
+292,172
+17% +$1.51M ﹤0.01% 2208
2024
Q1 		$7.08M Sell
1,721,635
-246,350
-13% -$986K ﹤0.01% 2453
2023
Q4 		$8.31M Sell
1,967,985
-196,573
-9% -$793K ﹤0.01% 2393
2023
Q3 		$9.35M Buy
2,164,558
+215,175
+11% +$1.2M ﹤0.01% 2293
2023
Q2 		$12.8M Sell
1,949,383
-834,307
-30% -$5.35M ﹤0.01% 2142
2023
Q1 		$18.9M Sell
2,783,690
-70,142
-2% -$493K 0.01% 1932
2022
Q4 		$21.1K Buy
2,853,832
+118,856
+4% +$1.16M 0.01% 1847
2022
Q3 		$27M Buy
2,734,976
+54,951
+2% +$580K 0.01% 1648
2022
Q2 		$29.2M Buy
2,680,025
+416,866
+18% +$4.32M 0.01% 1653
2022
Q1 		$25.6M Buy
2,263,159
+229,581
+11% +$3.02M 0.01% 1839
2021
Q4 		$31.9M Buy
2,033,578
+103,696
+5% +$1.81M 0.01% 1725
2021
Q3 		$33.1M Sell
1,929,882
-36,545
-2% -$640K 0.01% 1720
2021
Q2 		$42.3M Buy
1,966,427
+238,066
+14% +$4.26M 0.01% 1572
2021
Q1 		$26M Buy
1,728,361
+176,123
+11% +$2.85M 0.01% 1903
2020
Q4 		$20.4M Buy
1,552,238
+84,573
+6% +$1.02M 0.01% 1977
2020
Q3 		$14.2M Buy
1,467,665
+34,657
+2% +$370K 0.01% 2034
2020
Q2 		$16.4M Buy
1,433,008
+97,663
+7% +$1.11M 0.01% 1966
2020
Q1 		$13.8M Buy
1,335,345
+137,624
+11% +$1.71M 0.01% 1952
2019
Q4 		$19.7M Buy
1,197,721
+76,805
+7% +$1.16M 0.01% 2053
2019
Q3 		$14.9M Buy
1,120,916
+153,512
+16% +$2.14M 0.01% 2164
2019
Q2 		$13.6M Buy
967,404
+182,786
+23% +$2.91M 0.01% 2258
2019
Q1 		$14.4M Buy
784,618
+253,913
+48% +$5.79M 0.01% 2228
2018
Q4 		$13.9M Buy
530,705
+270,795
+104% +$6.37M 0.01% 2186
2018
Q3 		$5.96M Buy
+259,910
New +$5.31M ﹤0.01% 2627
2016
Q3 		– Sell
-25,128
Closed -$281K – 3284
2016
Q2 		$281K Hold
25,128
– – ﹤0.01% 3131
2016
Q1 		$210K Buy
25,128
+2,000
+9% +$16.4K ﹤0.01% 3174
2015
Q4 		$215K Buy
23,128
+1,900
+9% +$19K ﹤0.01% 3207
2015
Q3 		$239K Buy
21,228
+3,300
+18% +$40.4K ﹤0.01% 3222
2015
Q2 		$228K Buy
+17,928
New +$193K ﹤0.01% 3232

Other funds holding VNDA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
AIGH Capital Management Baltimore, Maryland $733M AUM 327.32% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Dimensional Fund Advisors's VNDA Position: Q1 2026 in Review

Dimensional Fund Advisors reduced its Vanda Pharmaceuticals (VNDA) stake by 16% in Q1 2026, selling an estimated $2.67M and leaving 1,771,593 shares worth $12.2M. The position accounts for ﹤0.01% of the portfolio, ranked #2180.

Dimensional Fund Advisors first reported a position in VNDA in Q2 2015 and has held it in 36 quarters since. The position peaked at $42.3M in Q2 2021. 170 funds tracked by Wall St. Rank hold VNDA as of Q1 2026.

  • Dimensional Fund Advisors held 1,771,593 shares of Vanda Pharmaceuticals worth $12.2M as of Q1 2026.
  • Dimensional Fund Advisors sold 346,835 Vanda Pharmaceuticals shares in Q1 2026, an estimated $2.67M.
  • Vanda Pharmaceuticals made up ﹤0.01% of Dimensional Fund Advisors's portfolio in Q1 2026, its #2180 holding.
  • Dimensional Fund Advisors first reported a position in Vanda Pharmaceuticals in Q2 2015 and has held it in 36 quarters since.
  • Dimensional Fund Advisors's Vanda Pharmaceuticals position peaked at $42.3M in Q2 2021.
  • 170 funds tracked by Wall St. Rank held Vanda Pharmaceuticals as of Q1 2026.

Based on Dimensional Fund Advisors's 13F filing for Q1 2026, filed 7 May 2026.